Categories
GeekWire

Allen Frontiers Group boosts biomedicine

Molecular structure
Three Allen Distinguished Investigator projects focus on epigenetics, or how genes are turned on and off. Researchers will study how the 3-D shape of the genome and the presence of regulatory molecules impact the behavior of cells.(Molekuul.be via Paul G. Allen Frontiers Group)

Epigenetics, aging and microbial evolution: Those are the latest words in biomedical research for the Paul G. Allen Frontiers Group, backed up with $7.5 million in awards for five teams of scientists.

Each of the teams will receive $1.5 million over the next three years to boost early-stage studies that have the potential to yield medical breakthroughs.

“It’s part of Paul Allen’s growing commitment to the idea that this is the century of bioscience,” Tom Skalak, executive director of the Seattle-based Frontiers Group, told GeekWire. Allen, one of the founders of Microsoft, launched the Frontiers Group last year with a $100 million commitment.

Get the full story on GeekWire.

By Alan Boyle

Mastermind of Cosmic Log, contributing editor at GeekWire, author of "The Case for Pluto: How a Little Planet Made a Big Difference," president of the Council for the Advancement of Science Writing. Check out "About Alan Boyle" for more fun facts.

Leave a Reply